LEDGF hybrids efficiently retarget lentiviral integration into heterochromatin

Molecular Therapy

Volumn 18, Issue 3, 2010, Pages 552-560

  Gijsbers, Rik ^a   Ronen, Keshet ^b   Vets, Sofie ^a   Malani, Nirav ^b   De Rijck, Jan ^a   McNeely, Melissa ^a   Bushman, Frederic D ^b   Debyser, Zeger ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; HISTONE H3; INTEGRASE; LENS EPITHELIUM DERIVED GROWTH FACTOR; LENTIVIRUS VECTOR; PROTEIN CBX1; PROTEIN P75; UNCLASSIFIED DRUG;

ARTICLE; CELL LINE; CONTROLLED STUDY; DNA INTEGRATION; EPIGENETICS; GENE EXPRESSION; GENE SILENCING; GENE TARGETING; GENETIC ENGINEERING; HETEROCHROMATIN; HUMAN; HUMAN CELL; LASER MICROSCOPY; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN BINDING; VIRAL GENE DELIVERY SYSTEM; VIRUS INFECTION; WESTERN BLOTTING;

LENTIVIRUS;

EID: 77649250416     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2010.36     Document Type: Article

References (74)

1. Dietz, F, Franken, S, Yoshida, K, Nakamura, H, Kappler, J and Gieselmann, V (2002). The family of hepatoma-derived growth factor proteins: characterization of a new member HRP-4 and classifcation of its subfamilies. Biochem J 366(Pt 2): 491-500.
2. Shinohara, T, Singh, DP and Fatma, N (2002). LEDGF, a survival factor, activates stress-related genes. Prog Retin Eye Res 21: 341-358.
3. Maertens, G, Cherepanov, P, Pluymers, W, Busschots, K, De Clercq, E, Debyser, Z et al. (2003). LEDGF/p75 is essential for nuclear and chromosomal targeting of HIV-1 integrase in human cells. J Biol Chem 278: 33528-33539. (Pubitemid 37055807)
4. Llano, M, Vanegas, M, Fregoso, O, Saenz, D, Chung, S, Peretz, M et al. (2004). LEDGF/p75 determines cellular traffcking of diverse lentiviral but not murine oncoretroviral integrase proteins and is a component of functional lentiviral preintegration complexes. J Virol 78: 9524-9537.
5. Busschots, K, Vercammen, J, Emiliani, S, Benarous, R, Engelborghs, Y, Christ, F et al. (2005). The interaction of LEDGF/p75 with integrase is lentivirus-specifc and promotes DNA binding. J Biol Chem 280: 17841-17847.
6. Cherepanov, P, Devroe, E, Silver, PA and Engelman, A (2004). Identifcation of an evolutionarily conserved domain in human lens epithelium-derived growth factor/ transcriptional co-activator p75 (LEDGF/p75) that binds HIV-1 integrase. J Biol Chem 279: 48883-48892.
7. Cherepanov, P (2007). LEDGF/p75 interacts with divergent lentiviral integrases and modulates their enzymatic activity in vitro. Nucleic Acids Res 35: 113-124.
8. Maertens, G, Cherepanov, P, Debyser, Z, Engelborghs, Y and Engelman, A (2004). Identifcation and characterization of a functional nuclear localization signal in the HIV-1 integrase interactor LEDGF/p75. J Biol Chem 279: 33421-33429.
9. Vanegas, M, Llano, M, Delgado, S, Thompson, D, Peretz, M and Poeschla, E (2005). Identifcation of the LEDGF/p75 HIV-1 integrase-interaction domain and NLS reveals NLS-independent chromatin tethering. J Cell Sci 118(Pt 8): 1733-1743.
10. Vandekerckhove, L, Christ, F, Van Maele, B, De Rijck, J, Gijsbers, R, Van den Haute, C et al. (2006). Transient and stable knockdown of the integrase cofactor LEDGF/p75 reveals its role in the replication cycle of human immunodefciency virus. J Virol 80: 1886-1896.
11. Llano, M, Saenz, DT, Meehan, A, Wongthida, P, Peretz, M, Walker, WH et al. (2006). An essential role for LEDGF/p75 in HIV integration. Science 314: 461-464.
12. Ciuff, A, Llano, M, Poeschla, E, Hoffmann, C, Leipzig, J, Shinn, P et al. (2005). A role for LEDGF/p75 in targeting HIV DNA integration. Nat Med 11: 1287-1289.
13. Marshall, HM, Ronen, K, Berry, C, Llano, M, Sutherland, H, Saenz, D et al. (2007). Role of PSIP1/LEDGF/p75 in lentiviral infectivity and integration targeting. PLoS ONE 2: e1340.
14. Shun, MC, Raghavendra, NK, Vandegraaff, N, Daigle, JE, Hughes, S, Kellam, P et al. (2007). LEDGF/p75 functions downstream from preintegration complex formation to effect gene-specifc HIV-1 integration. Genes Dev 21: 1767-1778.
15. Schröder, AR, Shinn, P, Chen, H, Berry, C, Ecker, JR and Bushman, F (2002). HIV-1 integration in the human genome favors active genes and local hotspots. Cell 110: 521-529.
16. Ciuff, A and Bushman, FD (2006). Retroviral DNA integration: HIV and the role of LEDGF/p75. Trends Genet 22: 388-395.
17. Wang, GP, Ciuff, A, Leipzig, J, Berry, CC and Bushman, FD (2007). HIV integration site selection: analysis by massively parallel pyrosequencing reveals association with epigenetic modifcations. Genome Res 17: 1186-1194.
18. Hombrouck, A, De Rijck, J, Hendrix, J, Vandekerckhove, L, Voet, A, De Maeyer, M et al. (2007). Virus evolution reveals an exclusive role for LEDGF/p75 in chromosomal tethering of HIV. PLoS Pathog 3: e47.
19. De Rijck, J, Vandekerckhove, L, Gijsbers, R, Hombrouck, A, Hendrix, J, Vercammen, J et al. (2006). Overexpression of the lens epithelium-derived growth factor/p75 integrase binding domain inhibits human immunodefciency virus replication. J Virol 80: 11498-11509.
20. Maurer-Stroh, S, Dickens, NJ, Hughes-Davies, L, Kouzarides, T, Eisenhaber, F and Ponting, CP (2003). The Tudor domain 'Royal Family': Tudor, plant Agenet, Chromo, PWWP and MBT domains. Trends Biochem Sci 28: 69-74.
21. Turlure, F, Maertens, G, Rahman, S, Cherepanov, P and Engelman, A (2006). A tripartite DNA-binding element, comprised of the nuclear localization signal and two AT-hook motifs, mediates the association of LEDGF/p75 with chromatin in vivo. Nucleic Acids Res 34: 1653-1665.
22. Llano, M, Vanegas, M, Hutchins, N, Thompson, D, Delgado, S and Poeschla, EM (2006). Identifcation and characterization of the chromatin-binding domains of the HIV-1 integrase interactor LEDGF/p75. J Mol Biol 360: 760-773.
23. Shun, MC, Botbol, Y, Li, X, Di Nunzio, F, Daigle, JE, Yan, N et al. (2008). Identifcation and characterization of PWWP domain residues critical for LEDGF/p75 chromatin binding and human immunodefciency virus type 1 infectivity. J Virol 82: 11555-11567.
24. Meehan, AM, Saenz, DT, Morrison, JH, Garcia-Rivera, JA, Peretz, M, Llano, M et al. (2009). LEDGF/p75 proteins with alternative chromatin tethers are functional HIV-1 cofactors. PLoS Pathog 5: e1000522.
25. Ciuff, A, Diamond, TL, Hwang, Y, Marshall, HM and Bushman, FD (2006). Modulating target site selection during human immunodefciency virus DNA integration in vitro with an engineered tethering factor. Hum Gene Ther 17: 960-967.
26. Sun, D, Melegari, M, Sridhar, S, Rogler, CE and Zhu, L (2006). Multi-miRNA hairpin method that improves gene knockdown effciency and provides linked multi-gene knockdown. BioTechniques 41: 59-63.
27. Bustin, M, Catez, F and Lim, JH (2005). The dynamics of histone H1 function in chromatin. Mol Cell 17: 617-620.
28. Catez, F, Ueda, T and Bustin, M (2006). Determinants of histone H1 mobility and chromatin binding in living cells. Nat Struct Mol Biol 13: 305-310.
29. Maison, C and Almouzni, G (2004). HP1 and the dynamics of heterochromatin maintenance. Nat Rev Mol Cell Biol 5: 296-304.
30. Ochs, RL, Muro, Y, Si, Y, Ge, H, Chan, EK and Tan, EM (2000). Autoantibodies to DFS 70 kd/transcription coactivator p75 in atopic dermatitis and other conditions. J Allergy Clin Immunol 105(6 Pt 1): 1211-1220.
31. Llano, M, Delgado, S, Vanegas, M and Poeschla, EM (2004). Lens epithelium-derived growth factor/p75 prevents proteasomal degradation of HIV-1 integrase. J Biol Chem 279: 55570-55577.
32. Minc, E, Allory, Y, Courvalin, JC and Buendia, B (2001). Immunolocalization of HP1 proteins in metaphasic mammalian chromosomes. Methods Cell Sci 23: 171-174.
33. Hayakawa, T, Haraguchi, T, Masumoto, H and Hiraoka, Y (2003). Cell cycle behavior of human HP1 subtypes: distinct molecular domains of HP1 are required for their centromeric localization during interphase and metaphase. J Cell Sci 116: 3327-3338.
34. Ibrahimi, A, Vande Velde, G, Reumers, V, Toelen, J, Thiry, I, Vandeputte, C et al. (2009). Highly effcient multicistronic lentiviral vectors with peptide 2A sequences. Hum Gene Ther 20: 845-860.
35. Hacker, CV, Vink, CA, Wardell, TW, Lee, S, Treasure, P, Kingsman, SM et al. (2006). The integration profle of EIAV-based vectors. Mol Ther 14: 536-545.
36. Mitchell, RS, Beitzel, BF, Schroder, AR, Shinn, P, Chen, H, Berry, CC et al. (2004). Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PLoS Biol 2: E234.
37. Berry, C, Hannenhalli, S, Leipzig, J and Bushman, FD (2006). Selection of target sites for mobile DNA integration in the human genome. PLoS Comput Biol 2: e157.
38. Lachner, M, O'Carroll, D, Rea, S, Mechtler, K and Jenuwein, T (2001). Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature 410: 116-120.
39. Bannister, AJ, Zegerman, P, Partridge, JF, Miska, EA, Thomas, JO, Allshire, RC et al. (2001). Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain. Nature 410: 120-124.
40. Barski, A, Cuddapah, S, Cui, K, Roh, TY, Schones, DE, Wang, Z et al. (2007). High-resolution profling of histone methylations in the human genome. Cell 129: 823-837.
41. Wang, Z, Zang, C, Rosenfeld, JA, Schones, DE, Barski, A, Cuddapah, S et al. (2008). Combinatorial patterns of histone acetylations and methylations in the human genome. Nat Genet 40: 897-903.
42. Schotta, G, Lachner, M, Sarma, K, Ebert, A, Sengupta, R, Reuter, G et al. (2004). A silencing pathway to induce H3-K9 and H4-K20 trimethylation at constitutive heterochromatin. Genes Dev 18: 1251-1262.
43. Jones, B, Su, H, Bhat, A, Lei, H, Bajko, J, Hevi, S et al. (2008). The histone H3K79 methyltransferase Dot1L is essential for mammalian development and heterochromatin structure. PLoS Genet 4: e1000190.
44. Vogel, MJ, Guelen, L, de Wit, E, Peric-Hupkes, D, Lodén, M, Talhout, W et al. (2006). Human heterochromatin proteins form large domains containing KRAB-ZNF genes. Genome Res 16: 1493-1504.
45. Bushman, FD (1994). Tethering human immunodefciency virus 1 integrase to a DNA site directs integration to nearby sequences. Proc Natl Acad Sci USA 91: 9233-9237.
46. Holmes-Son, ML and Chow, SA (2002). Correct integration mediated by integrase-LexA fusion proteins incorporated into HIV-1. Mol Ther 5: 360-370.
47. Bushman, FD and Miller, MD (1997). Tethering human immunodefciency virus type 1 preintegration complexes to target DNA promotes integration at nearby sites. J Virol 71: 458-464.
48. Tan, W, Dong, Z, Wilkinson, TA, Barbas, CF 3rd and Chow, SA (2006). Human immunodefciency virus type 1 incorporated with fusion proteins consisting of integrase and the designed polydactyl zinc fnger protein E2C can bias integration of viral DNA into a predetermined chromosomal region in human cells. J Virol 80: 1939-1948.
49. Hare, S, Shun, MC, Gupta, SS, Valkov, E, Engelman, A and Cherepanov, P (2009). A novel co-crystal structure affords the design of gain-of-function lentiviral integrase mutants in the presence of modifed PSIP1/LEDGF/p75. PLoS Pathog 5: e1000259.
50. Geraerts, M, Michiels, M, Baekelandt, V, Debyser, Z and Gijsbers, R (2005). Upscaling of lentiviral vector production by tangential fow fltration. J Gene Med 7: 1299-1310.
51. Krause, DS, Theise, ND, Collector, MI, Henegariu, O, Hwang, S, Gardner, R et al. (2001). Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 105: 369-377.
52. Weiss, DJ, Kolls, JK, Ortiz, LA, Panoskaltis-Mortari, A and Prockop, DJ (2008). Stem cells and cell therapy approaches for lung diseases. Conference report. Proc Am Thorac Soc 5: 637-667.
53. Wong, AP, Keating, A, Lu, WY, Duchesneau, P, Wang, X, Sacher, A et al. (2009). Identifcation of a bone marrow-derived epithelial-like population capable of repopulating injured mouse airway epithelium. J Clin Invest 119: 336-348.
54. Wang, D, Morales, JE, Calame, DG, Alcorn, JL and Wetsel, RA (2010). Transplantation of human embryonic stem cell-derived alveolar epithelial type II cells abrogates acute lung injury in mice. Mol Ther 18: 625-634.
55. Zhao, YD, Courtman, DW, Deng, Y, Kugathasan, L, Zhang, Q and Stewart, DJ (2005). Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: effcacy of combined cell and eNOS gene therapy in established disease. Circ Res 96: 442-450.
56. Wang, XX, Zhang, FR, Shang, YP, Zhu, JH, Xie, XD, Tao, QM et al. (2007). Transplantation of autologous endothelial progenitor cells may be benefcial in patients with idiopathic pulmonary arterial hypertension: a pilot randomized controlled trial. J Am Coll Cardiol 49: 1566-1571.
57. Ward, MR, Stewart, DJ and Kutryk, MJ (2007). Endothelial progenitor cell therapy for the treatment of coronary disease, acute MI, and pulmonary arterial hypertension: current perspectives. Catheter Cardiovasc Interv 70: 983-998.
58. Nauta, AJ and Fibbe, WE (2007). Immunomodulatory properties of mesenchymal stromal cells. Blood 110: 3499-3506.
59. Gupta, N, Su, X, Popov, B, Lee, JW, Serikov, V and Matthay, MA (2007). Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. J Immunol 179: 1855-1863.
60. van Haaften, T, Byrne, R, Bonnet, S, Rochefort, GY, Akabutu, J, Bouchentouf, M et al. (2009). Airway delivery of mesenchymal stem cells prevents arrested alveolar growth in neonatal lung injury in rats. Am J Resp Crit Care Med 180:1131-1142.
61. Lee, JW, Fang, X, Gupta, N, Serikov, V and Matthay, MA (2009). Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung. Proc Natl Acad Sci USA 106: 16357-16362.
62. Osiris Therapeutics (2009). Osiris therapeutics reports interim data for COPD stem cell study. Press release http://investor.osiris.com/releasedetail. cfm? ReleaseID=391580 (23 June 2009).
63. Samadikuchaksaraei, A and Bishop, AE (2006). Derivation and characterization of alveolar epithelial cells from murine embryonic stem cells in vitro. Methods Mol Biol 330: 233-248.
64. Rippon, HJ, Polak, JM, Qin, M and Bishop, AE. Derivation of distal lung epithelial progenitors from murine embryonic stem cells using a novel three-step differentiation protocol. Stem Cells 24: 1389-1398.
65. Samadikuchaksaraei, A, Cohen, S, Isaac, K, Rippon, HJ, Polak, JM, Bielby, RC et al. (2006). Derivation of distal airway epithelium from human embryonic stem cells. Tissue Eng 12: 867-875.
66. Denham, M, Cole, TJ and Mollard, R (2006). Embryonic stem cells form glandular structures and express surfactant protein C following culture with dissociated fetal respiratory tissue. Am J Physiol Lung Cell Mol Physiol 290: L1210-L1215.
67. Wang, D, Haviland, DL, Burns, AR, Zsigmond, E and Wetsel, RA (2007). A pure population of lung alveolar epithelial type II cells derived from human embryonic stem cells. Proc Natl Acad Sci USA 104: 4449-4454.
68. Van Vranken, BE, Rippon, HJ, Samadikuchaksaraei, A, Trounson, AO and Bishop, AE (2007 July). The differentiation of distal lung epithelium from embryonic stem cells. Curr Protoc Stem Cell Biol Chapter 1: Unit 1G.1.
69. Winkler, ME, Mauritz, C, Groos, S, Kispert, A, Menke, S, Hoffmann, A et al. (2008). Serum-free differentiation of murine embryonic stem cells into alveolar type II epithelial cells. Cloning Stem Cells 10: 49-64.
70. Roszell, B, Mondrinos, MJ, Seaton, A, Simons, DM, Koutzaki, SH, Fong, GH et al. (2009) Effcient derivation of alveolar type II cells from embryonic stem cells for in vivo application. Tissue Eng Part A 15: 3351-3365.
71. Van Haute, L, De Block, G, Liebaers, I, Sermon, K and De Rycke, M. (2009). Generation of lung epithelial-like tissue from human embryonic stem cells. Respir Res 10: 105.
72. Coraux, C, Nawrocki-Raby, B, Hinnrasky, J, Kileztky, C, Gaillard, D, Dani, C et al. (2005). Embryonic stem cells generate airway epithelial tissue. Am J Respir Cell Mol Biol 32: 87-92.
73. Pickering, SJ, Minger, SL, Patel, M, Taylor, H, Black, C, Burns, CJ et al. (2005). Generation of a human embryonic stem cell line encoding the cystic fbrosis mutation deltaF508, using preimplantation genetic diagnosis. Reprod Biomed Online 10: 390-397.
74. Mateizel, I, De Temmerman, N, Ullmann, U, Cauffman, G, Sermon, K, Van de Velde, H et al. (2006). Derivation of human embryonic stem cell lines from embryos obtained after IVF and after PGD for monogenic disorders. Hum Reprod. 21: 503-511.